FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13195211000001101: Cabergoline 2mg tablets (Dowelhurst Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
46460701000001110 Cabergoline 2mg tablets (Dowelhurst Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
46460801000001118 Cabergoline 2mg tablets (Dowelhurst Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabergoline 2mg tablets (Dowelhurst Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Dowelhurst Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Dowelhurst Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Dowelhurst Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Dowelhurst Ltd) Is a Product containing precisely cabergoline 2 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Dowelhurst Ltd) Has active ingredient Cabergoline false Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Dowelhurst Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Dowelhurst Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Dowelhurst Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Dowelhurst Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Dowelhurst Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Dowelhurst Ltd) Has specific active ingredient Cabergoline true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Dowelhurst Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Dowelhurst Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cabergoline 2mg tablets (Dowelhurst Ltd) 20 tablet Is pack of False Cabergoline 2mg tablets (Dowelhurst Ltd) Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Dowelhurst Ltd) 20 tablet Has AMP True Cabergoline 2mg tablets (Dowelhurst Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start